FDA approves GSK’s Nucala for young children with severe eosinophilic asthma
Nucala is the only targeted biologic in the US to receive FDA approval for treating eosinophilic asthma in…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Sep 19
Nucala is the only targeted biologic in the US to receive FDA approval for treating eosinophilic asthma in…
09 Sep 19
The centre is set to nurture innovation by bringing together local and international companies, government, and medical and…
03 Sep 19
CHEPLAPHARM has selected Clinigen to distribute Etopophos and Vepesid in Australia and New Zealand as part of its…
25 Jun 19
The British Liver Trust is calling for urgent action as figures in their new report, ‘The Alarming Rise…
28 May 19
In light of new data which demonstrates that the cases of mumps has tripled in the first quarter…
28 May 19
Elderly patients with heart failure who see a pharmacist once a week are more likely to take their…
21 May 19
Bioengineers from UCLA Samueli School of Engineering have developed a new type of insulin that could help prevent hypoglycaemia in
23 Apr 19
A research roadmap has just been published in the journal Radiology, which highlights knowledge gaps in the literature
08 Apr 19
A clinical review, published at the end of last week in the BMJ, provides new interim advice for…
14 Jan 19
The latest NHS performance statistics show that A&E attendances were 3.6% higher in the last 12 months, compared…